Investigations:
Laboratory tests revealed elevated Thyroid-Stimulating Hormone (TSH) at 49.8 uIU/ml and low-normal Free T4 at 10.3 pmol/L, indicating hypothyroidism. Serum calcium was 9.18 mg/dl and parathyroid hormone (PTH) level was 35.5 pg/ml, within normal limits. Calcitonin was <0.500 pg/ml. Thyroglobulin was elevated at 62.6 ng/ml. Renal function tests and complete blood count were within normal limits, and viral screening was negative. Vocal cord examination showed normal mobility, shape, and color of both vocal cords.

Neck Ultrasound Findings:
Ultrasound of the neck showed remnant thyroid tissue in the right lobe operation bed measuring approximately 39 × 18 × 17 mm with inhomogeneous echotexture and multiple solid, hypoechoic, vascular nodules with microcalcifications, consistent with highly suspicious TR5 nodules or metastatic lymph nodes. Similar nodules were noted in the left thyroid bed and in the midline over the trachea extending retrosternally. Additionally, multiple suspicious cervical lymph nodes were identified bilaterally, with microcalcifications and loss of normal hilar architecture. The largest right-sided LN was 16 × 5 mm (group III), and the largest left-sided LN was 12 × 3 mm (group II). Submandibular and parotid glands appeared normal.

Fine Needle Aspiration Results:
FNA of the right TR5 nodule and bilateral cervical lymph nodes confirmed recurrence of papillary thyroid carcinoma. The right thyroid remnant was Bethesda category VI, and both right and left cervical lymph nodes tested positive for metastatic papillary thyroid carcinoma.

Histological examination confirmed metastatic papillary thyroid carcinoma involving 18 of 65 lymph nodes. Specifically:

• Right central group: 11 of 11 nodes involved.

• Left central group: 4 of 5 nodes involved.

• Right lateral group: 0 of 20 nodes involved.

• Left lateral group: 3 of 29 nodes involved.
  No residual thyroid tissue was seen; only skeletal muscle and fibrous tissue were identified at the thyroid bed.